Skip to main content

A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Gilead Sciences, Inc.

Start Date

October 12, 2022

End Date

October 31, 2027
 

Administered By

Duke Cancer Institute

Awarded By

Gilead Sciences, Inc.

Start Date

October 12, 2022

End Date

October 31, 2027